{"prompt": "['Clinical Study Protocol (CSP) GLPG1690-CL-204', 'Page 80/80', 'SIGNATURE PAGE - INVESTIGATOR', 'Study Title:', 'A Phase 2a randomized, double-blind, placebo-controlled, multi-center study', 'to evaluate the efficacy, safety, and tolerability of orally administered', 'GLPG1690 for 24 weeks in subjects with systemic sclerosis', 'CSP Version:', '5.00', 'Date:', '28-Apr-2020', 'I, the undersigned, have read this clinical study protocol and will conduct the study as described', 'in compliance with the clinical study protocol, in accordance with International Council for', 'Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)', 'guidelines for Good Clinical Practices (GCP) and applicable regulatory requirements.', 'Investigator Name', 'Signature', 'Date', 'Version 5.00, Final, 28-Apr-2020', 'Confidential Information']['Signature Page for glpg1690-cl-204-protocol 11151', 'Approval', 'al Director Phase I', 'Translational Medicine', '28-Apr-2020 14:26:27 GMT+0000', 'Signature Page for glpg1690-cl-204-protocol 11151']\n\n###\n\n", "completion": "END"}